TruaceTracing the truth around AIWednesday, August 26, 2026
TRV-2026-0041Certified recordOfficial statistics

Reveal linq: FDA malfunction report involving AI

The FDA received a malfunction report involving Reveal linq, made by Medtronic europe sarl. It was reported that the implantable cardiac monitor (icm) experienced false pause episodes due to undersensing. it was reported that representative stated the customer is concerned that the artificial intelligence (ai) algorithm adjudicated some pause episodes as false when they determined to be true. the icm remains in the patient. no patient complications have been reported as a result of this event.

Health · P Space — documented harm · certified 2026-07-12 · v2 · article view · machine-readable

Current reading — problem

Customer concern that the Reveal LINQ implantable monitor's AI adjudication classified true pause episodes as false, following undersensing and false pause episodes

What this doesn’t fix

Single MAUDE malfunction report; does not establish causality, incidence rate, or clinical outcome

Evidence

Reader signal

How should this claim be treated?

Cite this record

Truvace Impact Record TRV-2026-0041, v2: “Reveal linq: FDA malfunction report involving AI.” Truvace, 2026-07-13. /record/TRV-2026-0041 (accessed at citation time). sha256 d100d75a85e71578

Calibration history

Every change to this record since certification, in the open.

  1. Revisedv2d100d75a85e7

    Model backfill: grounded claim, summary, sector, and trace validation

  2. Certifiedv17682fc076a07

    Certified into the record

Verify this record
How to verify without trusting this page

Fetch the canonical text of any version from /api/record/TRV-2026-0041 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.